An Investigator-initiated, Explorative Trial Evaluating the Effect of SAT-008 in Healthy Adults — SAT-008

Allergy and Immunology Clinical Trial

Official title:
A Single-center, Randomized, Open Label, No-treatment Controlled, Digital Device Study to Evaluate the Efficacy, Safety and Feasibility of SAT-008 in Healthy Adults

Status Completed

Clinical Trial Summary

The purpose of this exploratory study is to evaluate the efficacy, safety, and feasibility of a novel digital device called SAT-008 in healthy adults.

Clinical Trial Description

This clinical study was designed as a single institution, open, controlled, and investigator-led clinical trial to evaluate the efficacy, safety, and feasibility of a novel digital device called SAT-008 in healthy adults. ;

Study Design

Related Conditions & MeSH terms

Allergy and Immunology

Clinical Trial Details

NCT number	NCT04916145
Study type	Interventional
Source	Seoul National University Bundang Hospital
Contact
Status	Completed
Phase	N/A
Start date	October 8, 2020
Completion date	January 25, 2021

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT06260956` - Expecting Mother's Study of Consumption or Avoidance of Peanut and Egg	N/A
Completed	`NCT03763630` - MAPS & ITEC Cohorts: 6-8 Years Follow-up	Phase 2
Completed	`NCT04523246` - Training the Innate Immune System Against SARS-CoV-2 (COVID-19) Using the Shingrix Vaccine in Nursing Home Residents	Early Phase 1
Recruiting	`NCT05394363` - Generation Victoria Cohort 2020s: A Statewide Longitudinal Cohort Study of Victorian Children and Their Parents
Recruiting	`NCT05323357` - Bern Human Organoid-Study to Study Host-microbe Interaction
Recruiting	`NCT04438629` - Evaluation of Immune Response in COVID-19 Patients
Terminated	`NCT02559258` - Escalating Single Dose Study of Epsi- Gam in Healthy Normal Subjects	Phase 1
Recruiting	`NCT04751760` - Feasibility Study of a New Immunoglobulin E (IgE) Assay Method